Tyra Biosciences, Inc. (TYRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.57B |
| Enterprise Value | 1.5B |
| P/E Ratio | -8.14 |
| PEG Ratio | 0.26 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.14 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.23 |
| Return On Equity | -0.4 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -119.4M |
| Net Income | -119.95M |
| Diluted EPS | -2.01 |
| Total Cash | 700.55M |
| Total Cash/Share | 10.14 |
| Total Debt | 5.46M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 23.93 |
| Book Value Per Share | 10.03 |
| 52-Week Change | 48.2 |
| 52-Week High | 40.65 |
| 52-Week Low | 13.83 |
| Moving Average 50 Days | 22.12 |
| Moving Average 200 Days | 29.63 |
| Average Volume | 835,021 |
| Shares Outstanding | 59.66M |
| % Held by Institutions | 112.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |